Infrared (波姆)spectral therapeutic equipment

Figure 1. Console model infrared spectral therapeutic equipment

Figure 2. Table-type infrared spectral therapeutic equipment

¨ Fundamental Theory:

The infrared condensational method is introduced to the equipment, which is a popular therapeutic method in the world. Because the human body can absorb the light of some specific wavelength selectively, the equipment uses the thermal the infrared radiation on the surface of pathologic tissues to create the heat-cure effect and the biologic resonance absorber effect, and these effects would make the coagulation, scab, and desquamation of the pathologic-change tissues, accelerate the restoration and regeneration of the tissue, ameliorate the microcirculation and nourishment of the tissue, enhance the immunologic function of the body, and increases the activity of the cell.

¨ Features:

Minitype, Simple operation, High safety and reliability

Non-minus effect, short therapeutic time, little pain and no hospitalization. Adapt to be popularized and used in clinic and primary medical institution.

No charring, no gasification, no off-flavor and no environmental pollution during an operation.

No adhesion and no scar after an operation

Smooth and elastic surface of wound.

Better than 电熨, freezing and laser methods

It is a perfect novel therapeutic equipment for Department of Gynecology, Department of Dermatology, surgery and Department of stomatology.

¨ Scope of application

n Department of Gynaecology and Obstetrics: cerical erosion, cervicitis, leukoplakia vulvae, cervical polyp, pruritus vulvae, chronic pelvic inflammatory disease, chronic salpingitis, wound infection of mediolateral episiotomy, hyperplasia of lobule of mammary gland, and etc.

n Department of Dermatology : pointed condyloma, verruca plana, herpes simplex, erysipelas, ulceration of skin, and etc.

n surgery: wound infection, soft tissue injury, frostbite, and etc.

n Department of Stomatology: ulceration of mouth cavity, vesicant flat moss, periodontitis, and etc.

Anorectal Department: internal hemorrhoid and the internal part of mixed hemorrhoid.

Since its establishment in 1997, Tianlong has been committed to the research and development, production and overall solutions of instruments and in vitro diagnostic reagents in the field of genetic testing and molecular diagnostics. With its own sustainable development and potential values, Tianlong has received investments from SK Group, the 57th largest company in the Fortune Global 500 list, and Kehua Bio-Engineering, a listed company in China, in 2012 and 2018.



As a high-tech enterprise in China, Tianlong Technology is responsible for many major scientific research and industrialization projects such as the National Key Research and Development Program, the National Special Project for the Development of Major Scientific Instruments and Equipment, and the National Science and Technology Support Program. ISO9001-certified and 13485-standard, Tianlong now has hundreds of products such as nucleic acid extractor, automated nucleic acid workstation, gene amplification instruments, real-time PCR instruments, ATP fluorescence detector and supporting test reagents. over 50 products have been approved by NMPA with medical device registration certificates, and more than 20 products have been approved by EU (CE) and KFDA (South Korea).



Tianlong products are widely applied in the fields of medical diagnosis, food safety, epidemic prevention and control, customs and quarantine, forensics, scientific research, etc., and have contributed to the prevention and control of various major epidemics such as avian flu, Ebola, MERS, African swine fever and neonatal pneumonia. At present, Tianlong is serving more than 2,000 customers in more than 40 countries and regions including, Korea, the United States, France, Germany, Denmark, the United Arab Emirates, Pakistan, and so on.



At the end of 2019, after the outbreak of the COVID-19 epidemic, Tianlong quickly launched SARS-CoV-2 rapid nucleic acid detection solution, successively detected the first positive samples in many provinces in China, and made a great contribution to the epidemic prevention and control globally. Tianlong successively received letters of thanks from the State Council of China, the National Center for Disease Control of China, and the Slovakian government. Tianlong was then reported by CCTV News, Xinhua News Agency, People's Daily and other authoritative media.



In the face of future opportunities and challenges, we will continue to create first-class molecular diagnostic products and work hard for human health in a more open way of cooperation with all walks of life.